Benefit-sharing from DSI rests on the provider country's national framework. Where it requires bilateral benefit-sharing for DSI, those terms apply. Where it gives effect to the CBD multilateral mechanism, users of its publicly available DSI should share benefits through it: all users non-monetary benefits, as appropriate, and commercial users above set size thresholds also monetary contributions to the Cali Fund. Where it is silent on DSI, the position is not yet settled: check with the country's competent national authority, through the ABS service. Any terms agreed when the genetic resources were accessed still apply. Access and benefit-sharing questions are handled by the ABS service, not by the DataBank. Learn more →
Light/fluorescence microscopy of cells & tissues, and electron/cryo-EM imaging of macromolecular structures — a metadata catalog with a durable link back to the source archive, not a hosted image gallery. These are primary research datasets (often multi-GB to multi-TB), so this platform never downloads or stores the underlying imaging data itself. Datasets already in either source archive are ingested via accession paste/CSV at /mirroring by a Continental Admin (no automated harvesting — neither source archive supports geography-filterable search); a dataset not yet in either archive can instead be submitted directly below by any node operator, for Continental Admin review. Either way, whoever submits an accession or a self-submitted dataset is the one asserting African origin — this platform does not verify it.
Heterotrophic bacteria rapidly deplete essential macronutrients during growth and must navigate subsequent periods of growth arrest imposed by starvation. Nutrient limitations can be dynamic in nature, requiring ongoing regulatory adjustments involving new protein synthesis despite total biosynthetic activities being dramatically lower than during growth. Here, we have characterized the responses of the opportunistic pathogen Pseudomonas aeruginosa to prolonged starvation for carbon or nitrogen sources, and to transitions between these states. We find that most cells survive both types of starvation for more than a week and maintain low but robustly detectable levels of protein synthesis in the absence of growth. Nitrogen-starved cells are larger, make more proteins and retain fewer ribosomes than carbon-starved cells, indicating that distinct physiological strategies are adopted during the two starvation types. We found that the newly synthesized proteomes of each starvation type are distinct, although many of the most highly synthesized proteins are shared between both conditions. Interestingly, we observed a temporary burst of protein synthesis as cells were transitioned between the two starvation conditions, which may reflect active remodelling of the proteome during growth arrest. We also used transposon insertion sequencing to identify genes impacting fitness in both starvation conditions and during transitions between the two and found that a highly overlapping set of global regulators most strongly influenced survival. Combining these datasets, we highlight proteases and chaperones; flagellar motility; and the nitrogen-related phosphotransferase system as key fitness-impacting functions that are actively maintained by growth arrested Pseudomonas aeruginosa.
Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome
BioImage Archive:S-BIAD2625 · (University of Liverpool) · Pseudomonas protegens
Microbial keratitis, infection of the cornea, cause by ExotoxinU (ExoU) strains of Pseudomonas aeruginosa have a poor clinical outcome and response to antimicrobials. ExoU, a phospholipase, is secreted directly into host cells, causing their lysis. A screen of 3,034 FDA-approved compounds identified zinc pyrithione (Zp), bismuth subcitrate (Bis), and polymyxin B (Pol) as lead inhibitors of ExoU selectively inhibiting it without affecting human PLA2s or bacterial viability. The compounds have distinct inhibitory mechanisms: Zp disrupted ExoU oligomerization and protein stability; Bis impaired phosphatidylinositol 4,5-bisphosphate-dependent membrane association; Pol directly inhibited catalysis via its lipid-peptide architecture. Compound combinations enhanced ExoU inhibition in vitro to nanomolar concentrations. In mammalian cells, Bis and Pol promoted lysosomal trafficking and degradation of ExoU. Using a high-throughput microscopy platform, we screened 53 P. aeruginosa keratitis isolates, confirming broad efficacy of these inhibitors in exoU⁺ strains. Therapeutic efficacy was evaluated in ex vivo porcine corneas, Galleria mellonella, and in vivo mouse keratitis models. Topical delivery of ExoU inhibitors, particularly in combination, significantly reduced corneal opacity, ulceration, and stromal damage in porcine corneas without affecting bacterial load. In Galleria, compound combinations significantly maintained larval health, improved larval survival and delayed mortality. In a mouse eye infection model, combinatorial treatment reduced disease severity and preserved tissue viability without altering bacterial burden. These findings validate ExoU as a druggable virulence factor and support the repurposing of these compounds as an anti-virulence strategy for the treatment of P. aeruginosa infections in humans and veterinary medicine.
Nontuberculous mycobacteria (NTM) infections are increasing in incidence and mortality worldwide. This study investigates the roles of Toll-like receptor 2 (TLR2) and the microbiome in orchestrating immune responses in NTM infection. Using a zebrafish larval model, we studied uptake of two NTM strains (Mycobacterium avium and M. marinum) through the gastrointestinal (GI) tract. We performed bacterial immersion experiments with these patho-gens using tlr2 mutant and wild-type zebrafish larvae in both germ-free (GF) and microbiome-colonized conditions. In wild-type microbiome-colonized larvae, M. avium predominantly localizes in the posterior gut, in contrast to an anterior-biased distribution for M. marinum. We found that both M. avium and M. marinum disseminate to posteri-or tissues after 2.5 days of immersion infection. Robotic gut microinjection confirms the protective roles of TLR2 and the microbiome against proliferation of M. avium and M. marinum. Expression analysis of downstream genes indicate that patterns of TLR2-dependent gene regulation differ between the two NTM species and show that the presence or absence of the microbiome differentially influences specific transcriptional responses to infection. Macrophage ablation studies show that macrophages facilitate dissemination of gut bacteria to distal tissues. Quantification of macrophages containing bacteria throughout the body show that the uptake of bacteria by mac-rophages depends on TLR2, but not on the microbiome. Using the same approach, TLR2 chemical antagonist treatment confirms the results observed in tlr2 mutant larvae. Live imaging of macrophage trajectories after bacte-rial gut microinjection show that macrophage motility after infection is impaired in tlr2 mutant larvae compared to the wild type. Notably, the effect of TLR2 on macrophage motility differs between GF and microbiome-colonized conditions. Our findings provide new insights into the coordinated roles of TLR2 signaling and the microbiome in controlling infection of mycobacteria via the gut and underscore the importance of TLR2 in macrophage function during mycobacterial gut infection
LeishTag: Leishmania protein subcellular localisation through the life cycle
BioImage Archive:S-BIAD4306 · (University of Oxford) · Mycobacterium tuberculosis TKK_03_0035
LeishTag is a sub-project of the LeishGEM project aiming to determine where the proteins of the unicellular eukaryotic pathogen Leishmania mexicana localise within the cell. Endogenous tagging of proteins at the N or C terminus with mNG, targeting Leishmania-specific proteins in both the promastigote and amastigote life cycle stages which lack a Trypanosoma brucei ortholog or with low sequence similarity (<20%) than the T. brucei ortholog, thereby complementing the TrypTag project's annotations.
Tatyana M. Svitkina, Gary G. Borisy (2011) CIL:24807, Xenopus laevis, keratocyte. CIL. Dataset
CIL:24807 · Xenopus laevis
Cultured cell/tissue image — not organismal specimen photography. Localization of XAC (Xenopus ADF/cofilin) in Xenopus keratocytes done with immuno-EM. A higher mag view of a localized region of the cell is shown in CIL 24808. Image corresponds to Figure 8g from J Cell Biol. 1999 May 31;145(5):1009-26. A fluorescence image showing XAC and phalloidin labelin is available as CIL 24807.
Nontuberculous mycobacteria (NTM) infections are increasing in incidence and mortality worldwide. This study investigates the roles of Toll-like receptor 2 (TLR2) and the microbiome in orchestrating immune responses in NTM infection. Using a zebrafish larval model, we studied uptake of two NTM strains (Mycobacterium avium and M. marinum) through the gastrointestinal (GI) tract. We performed bacterial immersion experiments with these patho-gens using tlr2 mutant and wild-type zebrafish larvae in both germ-free (GF) and microbiome-colonized conditions. In wild-type microbiome-colonized larvae, M. avium predominantly localizes in the posterior gut, in contrast to an anterior-biased distribution for M. marinum. We found that both M. avium and M. marinum disseminate to posteri-or tissues after 2.5 days of immersion infection. Robotic gut microinjection confirms the protective roles of TLR2 and the microbiome against proliferation of M. avium and M. marinum. Expression analysis of downstream genes indicate that patterns of TLR2-dependent gene regulation differ between the two NTM species and show that the presence or absence of the microbiome differentially influences specific transcriptional responses to infection. Macrophage ablation studies show that macrophages facilitate dissemination of gut bacteria to distal tissues. Quantification of macrophages containing bacteria throughout the body show that the uptake of bacteria by mac-rophages depends on TLR2, but not on the microbiome. Using the same approach, TLR2 chemical antagonist treatment confirms the results observed in tlr2 mutant larvae. Live imaging of macrophage trajectories after bacte-rial gut microinjection show that macrophage motility after infection is impaired in tlr2 mutant larvae compared to the wild type. Notably, the effect of TLR2 on macrophage motility differs between GF and microbiome-colonized conditions. Our findings provide new insights into the coordinated roles of TLR2 signaling and the microbiome in controlling infection of mycobacteria via the gut and underscore the importance of TLR2 in macrophage function during mycobacterial gut infection
Chronic Pseudomonas aeruginosa lung infection is a major cause of morbidity and mortality in people with lung disease. Once established, infection is rarely eradicated and often persists despite prolonged antimicrobial therapy, but the mechanisms that support persistence in the human lung remain poorly understood. To define how P. aeruginosa occupies and adapts to diseased lung tissue, we applied host–pathogen spatial transcriptomics to explanted and resected lungs from people with Cystic Fibrosis (CF) and chronic obstructive pulmonary disease (COPD), mapping bacterial niches and transcriptional states in situ.
Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis
BioImage Archive:S-BSST1007 · Marco Kühn (École Polytechnique Fédérale de Lausanne) · Pseudomonas protegens
Source data for figures corresponding to the study: Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis. DOI: https://doi.org/10.15252/embj.2022112165
Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis
BioImage Archive:S-BSST1007 · Marco Kühn (École Polytechnique Fédérale de Lausanne) · Pseudomonas amygdali pv. morsprunorum
Source data for figures corresponding to the study: Two antagonistic response regulators control Pseudomonas aeruginosa polarization during mechanotaxis. DOI: https://doi.org/10.15252/embj.2022112165
Topical Formulation of Repurposed FDA-Approved Compounds Inhibits Pseudomonas aeruginosa ExoU and Improves Corneal Infection Outcome
BioImage Archive:S-BIAD2625 · (University of Liverpool) · Pseudomonas protegens
Microbial keratitis, infection of the cornea, cause by ExotoxinU (ExoU) strains of Pseudomonas aeruginosa have a poor clinical outcome and response to antimicrobials. ExoU, a phospholipase, is secreted directly into host cells, causing their lysis. A screen of 3,034 FDA-approved compounds identified zinc pyrithione (Zp), bismuth subcitrate (Bis), and polymyxin B (Pol) as lead inhibitors of ExoU selectively inhibiting it without affecting human PLA2s or bacterial viability. The compounds have distinct inhibitory mechanisms: Zp disrupted ExoU oligomerization and protein stability; Bis impaired phosphatidylinositol 4,5-bisphosphate-dependent membrane association; Pol directly inhibited catalysis via its lipid-peptide architecture. Compound combinations enhanced ExoU inhibition in vitro to nanomolar concentrations. In mammalian cells, Bis and Pol promoted lysosomal trafficking and degradation of ExoU. Using a high-throughput microscopy platform, we screened 53 P. aeruginosa keratitis isolates, confirming broad efficacy of these inhibitors in exoU⁺ strains. Therapeutic efficacy was evaluated in ex vivo porcine corneas, Galleria mellonella, and in vivo mouse keratitis models. Topical delivery of ExoU inhibitors, particularly in combination, significantly reduced corneal opacity, ulceration, and stromal damage in porcine corneas without affecting bacterial load. In Galleria, compound combinations significantly maintained larval health, improved larval survival and delayed mortality. In a mouse eye infection model, combinatorial treatment reduced disease severity and preserved tissue viability without altering bacterial burden. These findings validate ExoU as a druggable virulence factor and support the repurposing of these compounds as an anti-virulence strategy for the treatment of P. aeruginosa infections in humans and veterinary medicine.